1
An Open-Label Study of 50 mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women With Low Testosterone and HSDD
Condition(s):Hypoactive Sexual Desire DisorderLast Updated:October 16, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hypoactive Sexual Desire DisorderLast Updated:October 16, 2023Not yet recruiting
Condition(s):Stress Urinary Incontinence; Urge IncontinenceLast Updated:October 10, 2023Recruiting
Condition(s):DyspareuniaLast Updated:June 9, 2022Completed
Condition(s):Hypoactive Sexual Desire DisorderLast Updated:June 13, 2022Terminated
Condition(s):Vulvovaginal Atrophy; DyspareuniaLast Updated:April 2, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.